Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients

Cesare Gridelli, Silvia Novello, Nicoletta Zilembo, Andrea Luciani, Adolfo Gino Favaretto, Filippo De Marinis, Giovenzio Genestreti, Lucio Crinò, Francesco Grossi, Orazio Caffo, Francesco Ferraù, Giorgio Cruciani, Alba Ariela Brandes, Domenico Galetta, Sandro Barni, Gianpiero Fasola, Giulio Cerea, Silvia Ferrari, Claudio Iannacone, Fortunato Ciardiello

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients'. Together they form a unique fingerprint.

Medicine & Life Sciences